Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Human EGFR Monoclonal Antibody, Endotoxin 0.05 EU/mg

Product Sizes
5 mg
£1095.00
YR0026-5MG
20 mg
£2138.00
YR0026-20MG
About this Product
SKU:
YR0026
Additional Names:
ERBB|ERBB1|ERRP|HER1|mENA|NISBD2|PIG61
Application:
Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
Clonality:
Monoclonal
Extra Details:
Cetuximab, a chimeric (mouse/human) anti-EGFR monoclonal antibody, is an EGFR inhibitor used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab binds to EGFR and turns off the uncontrolled growth in cancers with EGFR mutations.Cetuximab can be used for treatment of KRAS wild type colon cancer but has little or no effect in colorectal tumors harboring a KRAS mutation. Before treatment using Erbitux, it is better to do a diagnosis using the real time PCR companion diagnostic test for KRAS, the therascreen KRAS test.
Formulation:
Purified from cell culture supernatant in an animal-free facility
Immunogen:
Human EGFR
Isotype:
IgG1, kappa
Molecular Weight:
150 kDa
Purity:
>95%
Shipping Conditions:
Blue Ice
Storage Conditions:
2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
Supplier:
ABclonal Technology
Type:
Antibody: Biosimilar Antibody
  • Manufacturer's Data Sheet:YR0026